"Finally, we show that (S)-PHA533533 unsilences paternal UBE3A in Angelman syndrome (AS) patient-derived neurons, highlighting its translational potential. Our findings provide a lead for developing a small molecule treatment for AS that could be safe, non-invasively delivered, and capable of brain-wide unsilencing of paternal #UBE3A."